TheProfitWatch

FULC - Fulcrum Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
11.3 -0.04 (-0.4%) -0.01 (-0.09%) -0.06 (-0.53%) 0.04 (0.31%) -0.69 (-6.11%) 0.26 (2.32%) 0.22 (1.99%) -0.45 (-4.07%)

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.28
Diluted EPS:
-0.28
Basic P/E:
-40.1964
Diluted P/E:
-40.1964
RSI(14) 1m:
52.94
VWAP:
11.25
RVol:

Events

Period Kind Movement Occurred At

Related News